Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors
- PMID: 32092586
- DOI: 10.1016/j.ejmech.2020.112107
Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors
Abstract
Ubiquitin-specific-processing protease 7 (USP7) is one among the several deubiquitinating enzymes gaining central attention in the current cancer research. Most recent studies have focused on illustrating how USP7 is involved in the cancer process, while few articles reported the development of small molecule USP7 inhibitors. Although some review articles dealt with USP7, they mainly focused on its physiological role and not on the development of USP7 inhibitors. In this review, we systematically summarise the structures, activities and structure-activity relationship (SAR) of small molecule USP7 inhibitors, recently disclosed in scientific articles and patents from 2000 to 2019. The binding modes of typical compounds and their interactions with USP7 are also presented, while other deubiquitinase inhibitors are described in detail. Meanwhile, we briefly introduce the biochemical and physiological functions of USP7. Finally, challenges and potential strategies in developing small molecule USP7 inhibitors are also discussed.
Keywords: Cancer; Inhibitors; SAR; USP7; Ubiquitination.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
USP7: Target Validation and Drug Discovery for Cancer Therapy.Med Chem. 2018;14(1):3-18. doi: 10.2174/1573406413666171020115539. Med Chem. 2018. PMID: 29065837 Review.
-
USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.Cell Chem Biol. 2017 Dec 21;24(12):1501-1512.e5. doi: 10.1016/j.chembiol.2017.09.004. Epub 2017 Oct 19. Cell Chem Biol. 2017. PMID: 29056420
-
Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery.Eur J Med Chem. 2025 Oct 15;296:117872. doi: 10.1016/j.ejmech.2025.117872. Epub 2025 Jun 18. Eur J Med Chem. 2025. PMID: 40544656 Review.
-
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.Cell Chem Biol. 2017 Dec 21;24(12):1490-1500.e11. doi: 10.1016/j.chembiol.2017.09.003. Epub 2017 Oct 19. Cell Chem Biol. 2017. PMID: 29056421 Free PMC article.
-
A patent review of ubiquitin-specific protease 7 (USP7) inhibitors (2014-present).Expert Opin Ther Pat. 2022 Jul;32(7):753-767. doi: 10.1080/13543776.2022.2058873. Epub 2022 Mar 31. Expert Opin Ther Pat. 2022. PMID: 35343357 Review.
Cited by
-
USP7 regulates growth and maintains the stemness of p53-mutant colorectal cancer cells via stabilizing of mutant p53.Front Oncol. 2024 Sep 12;14:1427663. doi: 10.3389/fonc.2024.1427663. eCollection 2024. Front Oncol. 2024. PMID: 39346740 Free PMC article.
-
Fungal Secondary Metabolites as Inhibitors of the Ubiquitin-Proteasome System.Int J Mol Sci. 2021 Dec 10;22(24):13309. doi: 10.3390/ijms222413309. Int J Mol Sci. 2021. PMID: 34948102 Free PMC article. Review.
-
Comprehensive Analysis of Universal Stress Protein Family Genes and Their Expression in Fusarium oxysporum Response of Populus davidiana × P. alba var. pyramidalis Louche Based on the Transcriptome.Int J Mol Sci. 2023 Mar 11;24(6):5405. doi: 10.3390/ijms24065405. Int J Mol Sci. 2023. PMID: 36982480 Free PMC article.
-
Targeting ubiquitin signaling for cancer immunotherapy.Signal Transduct Target Ther. 2021 Jan 13;6(1):16. doi: 10.1038/s41392-020-00421-2. Signal Transduct Target Ther. 2021. PMID: 33436547 Free PMC article. Review.
-
Highlights in USP7 inhibitors for cancer treatment.Front Chem. 2022 Sep 15;10:1005727. doi: 10.3389/fchem.2022.1005727. eCollection 2022. Front Chem. 2022. PMID: 36186590 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous